<?xml version="1.0" ?>
<!DOCTYPE PubmedArticleSet PUBLIC "-//NLM//DTD PubMedArticle, 1st January 2024//EN" "https://dtd.nlm.nih.gov/ncbi/pubmed/out/pubmed_240101.dtd">
<PubmedArticleSet>
<PubmedArticle><MedlineCitation Status="MEDLINE" Owner="NLM"><PMID Version="1">33262488</PMID><DateCompleted><Year>2021</Year><Month>04</Month><Day>01</Day></DateCompleted><DateRevised><Year>2021</Year><Month>04</Month><Day>01</Day></DateRevised><Article PubModel="Electronic"><Journal><ISSN IssnType="Electronic">2045-2322</ISSN><JournalIssue CitedMedium="Internet"><Volume>10</Volume><Issue>1</Issue><PubDate><Year>2020</Year><Month>Dec</Month><Day>01</Day></PubDate></JournalIssue><Title>Scientific reports</Title><ISOAbbreviation>Sci Rep</ISOAbbreviation></Journal><ArticleTitle>Epidemical and etiological study on hand, foot and mouth disease following EV-A71 vaccination in Xiangyang, China.</ArticleTitle><Pagination><StartPage>20909</StartPage><MedlinePgn>20909</MedlinePgn></Pagination><ELocationID EIdType="pii" ValidYN="Y">20909</ELocationID><ELocationID EIdType="doi" ValidYN="Y">10.1038/s41598-020-77768-7</ELocationID><Abstract><AbstractText>Coxsackievirus A6 (CV-A6) and Coxsackievirus A10 (CV-A10) have been emerging as the prevailing serotypes and overtaking Enterovirus A71 (EV-A71) and Coxsackievirus A16 (CV-A16) in most areas as main pathogens of hand, foot and mouth disease (HFMD) in China since 2013. To investigate whole etiological spectrum following EV-A71 vaccination of approximate 40,000 infants and young children in Xiangyang, enteroviruses were serotyped in 4415 HFMD cases from October 2016 to December 2017 using Real Time and conventional PCR and cell cultures. Of the typeable 3201 specimen, CV-A6 was the predominant serotype followed by CV-A16, CV-A10, CV-A5, CV-A2 and EV-A71 with proportions of 59.54%, 15.31%, 11.56%, 4.56%, 3.78% and 3.03%, respectively. Other 12 minor serotypes were also detected. The results demonstrated that six major serotypes of enteroviruses were co-circulating, including newly emerged CV-A2 and CV-A5. A dramatic decrease of EV-A71 cases was observed, whereas the total cases remained high. Multivalent vaccines against major serotypes are urgently needed for control of HFMD.</AbstractText></Abstract><AuthorList CompleteYN="Y"><Author ValidYN="Y"><LastName>Meng</LastName><ForeName>Xiao-Dan</ForeName><Initials>XD</Initials><AffiliationInfo><Affiliation>Wuhan Institute of Biological Products Co. Ltd, Wuhan, 430207, China.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>National Engineering Technology Research Center of Combined Vaccines, No.1 Huangjin Industrial Park, Wuhan, 430207, Hubei, China.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Tong</LastName><ForeName>Yeqing</ForeName><Initials>Y</Initials><AffiliationInfo><Affiliation>Hubei Provincial Center for Diseases Control and Prevention, North Road 6# of Hongshan District, Wuhan, 430079, Hubei, China.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Wei</LastName><ForeName>Zhen-Ni</ForeName><Initials>ZN</Initials><AffiliationInfo><Affiliation>Wuhan Institute of Biological Products Co. Ltd, Wuhan, 430207, China.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>National Engineering Technology Research Center of Combined Vaccines, No.1 Huangjin Industrial Park, Wuhan, 430207, Hubei, China.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Wang</LastName><ForeName>Lei</ForeName><Initials>L</Initials><AffiliationInfo><Affiliation>Hubei Provincial Center for Diseases Control and Prevention, North Road 6# of Hongshan District, Wuhan, 430079, Hubei, China.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Mai</LastName><ForeName>Jian-Yi</ForeName><Initials>JY</Initials><AffiliationInfo><Affiliation>Wuhan Institute of Biological Products Co. Ltd, Wuhan, 430207, China.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>National Engineering Technology Research Center of Combined Vaccines, No.1 Huangjin Industrial Park, Wuhan, 430207, Hubei, China.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Wu</LastName><ForeName>Yang</ForeName><Initials>Y</Initials><AffiliationInfo><Affiliation>Hubei Provincial Center for Diseases Control and Prevention, North Road 6# of Hongshan District, Wuhan, 430079, Hubei, China.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Luo</LastName><ForeName>Zhi-Yu</ForeName><Initials>ZY</Initials><AffiliationInfo><Affiliation>Wuhan Institute of Biological Products Co. Ltd, Wuhan, 430207, China.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>National Engineering Technology Research Center of Combined Vaccines, No.1 Huangjin Industrial Park, Wuhan, 430207, Hubei, China.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Li</LastName><ForeName>Shaoping</ForeName><Initials>S</Initials><AffiliationInfo><Affiliation>Xiangyang Center for Disease Control and Prevention, Xiangyang, 441021, China.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Li</LastName><ForeName>Meng</ForeName><Initials>M</Initials><AffiliationInfo><Affiliation>Wuhan Institute of Biological Products Co. Ltd, Wuhan, 430207, China.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>National Engineering Technology Research Center of Combined Vaccines, No.1 Huangjin Industrial Park, Wuhan, 430207, Hubei, China.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Wang</LastName><ForeName>Siquan</ForeName><Initials>S</Initials><AffiliationInfo><Affiliation>Hubei Provincial Center for Diseases Control and Prevention, North Road 6# of Hongshan District, Wuhan, 430079, Hubei, China.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Wei</LastName><ForeName>Sheng</ForeName><Initials>S</Initials><AffiliationInfo><Affiliation>School of Public Health, Tongji Medical College, Huazhong University of Science and Technology, Wuhan, 430030, China.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Gong</LastName><ForeName>Wensheng</ForeName><Initials>W</Initials><AffiliationInfo><Affiliation>Xiangyang Center for Disease Control and Prevention, Xiangyang, 441021, China.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Zhang</LastName><ForeName>Wangsheng</ForeName><Initials>W</Initials><AffiliationInfo><Affiliation>Xiangyang Center for Disease Control and Prevention, Xiangyang, 441021, China.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Hu</LastName><ForeName>Xingzhou</ForeName><Initials>X</Initials><AffiliationInfo><Affiliation>Xiangyang Center for Disease Control and Prevention, Xiangyang, 441021, China.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Huang</LastName><ForeName>Jiao</ForeName><Initials>J</Initials><AffiliationInfo><Affiliation>School of Public Health, Tongji Medical College, Huazhong University of Science and Technology, Wuhan, 430030, China.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Shi</LastName><ForeName>Jing</ForeName><Initials>J</Initials><AffiliationInfo><Affiliation>Xiangyang Center for Disease Control and Prevention, Xiangyang, 441021, China.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Yang</LastName><ForeName>Gang</ForeName><Initials>G</Initials><AffiliationInfo><Affiliation>Xiangyang Center for Disease Control and Prevention, Xiangyang, 441021, China.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Meng</LastName><ForeName>Shengli</ForeName><Initials>S</Initials><AffiliationInfo><Affiliation>Wuhan Institute of Biological Products Co. Ltd, Wuhan, 430207, China.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>National Engineering Technology Research Center of Combined Vaccines, No.1 Huangjin Industrial Park, Wuhan, 430207, Hubei, China.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Wang</LastName><ForeName>Zejun</ForeName><Initials>Z</Initials><AffiliationInfo><Affiliation>Wuhan Institute of Biological Products Co. Ltd, Wuhan, 430207, China. wangzejun@sinopharm.com.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>National Engineering Technology Research Center of Combined Vaccines, No.1 Huangjin Industrial Park, Wuhan, 430207, Hubei, China. wangzejun@sinopharm.com.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Guan</LastName><ForeName>Xuhua</ForeName><Initials>X</Initials><AffiliationInfo><Affiliation>Hubei Provincial Center for Diseases Control and Prevention, North Road 6# of Hongshan District, Wuhan, 430079, Hubei, China. guanxh9999@163.com.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Shen</LastName><ForeName>Shuo</ForeName><Initials>S</Initials><AffiliationInfo><Affiliation>Wuhan Institute of Biological Products Co. Ltd, Wuhan, 430207, China. shenshuo1@sinopharm.com.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>National Engineering Technology Research Center of Combined Vaccines, No.1 Huangjin Industrial Park, Wuhan, 430207, Hubei, China. shenshuo1@sinopharm.com.</Affiliation></AffiliationInfo></Author></AuthorList><Language>eng</Language><PublicationTypeList><PublicationType UI="D016428">Journal Article</PublicationType><PublicationType UI="D013485">Research Support, Non-U.S. Gov't</PublicationType></PublicationTypeList><ArticleDate DateType="Electronic"><Year>2020</Year><Month>12</Month><Day>01</Day></ArticleDate></Article><MedlineJournalInfo><Country>England</Country><MedlineTA>Sci Rep</MedlineTA><NlmUniqueID>101563288</NlmUniqueID><ISSNLinking>2045-2322</ISSNLinking></MedlineJournalInfo><ChemicalList><Chemical><RegistryNumber>0</RegistryNumber><NameOfSubstance UI="D014765">Viral Vaccines</NameOfSubstance></Chemical></ChemicalList><CitationSubset>IM</CitationSubset><MeshHeadingList><MeshHeading><DescriptorName UI="D000818" MajorTopicYN="N">Animals</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D002675" MajorTopicYN="N">Child, Preschool</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D002681" MajorTopicYN="N" Type="Geographic">China</DescriptorName><QualifierName UI="Q000453" MajorTopicYN="N">epidemiology</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D002522" MajorTopicYN="N">Chlorocebus aethiops</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D029821" MajorTopicYN="N">Enterovirus A, Human</DescriptorName><QualifierName UI="Q000276" MajorTopicYN="Y">immunology</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D005260" MajorTopicYN="N">Female</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D006232" MajorTopicYN="N">Hand, Foot and Mouth Disease</DescriptorName><QualifierName UI="Q000517" MajorTopicYN="Y">prevention &amp; control</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D006801" MajorTopicYN="N">Humans</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D007223" MajorTopicYN="N">Infant</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D008297" MajorTopicYN="N">Male</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D014709" MajorTopicYN="N">Vero Cells</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D014765" MajorTopicYN="N">Viral Vaccines</DescriptorName><QualifierName UI="Q000008" MajorTopicYN="Y">administration &amp; dosage</QualifierName></MeshHeading></MeshHeadingList><CoiStatement>The authors declare no competing interests.</CoiStatement></MedlineCitation><PubmedData><History><PubMedPubDate PubStatus="received"><Year>2020</Year><Month>9</Month><Day>11</Day></PubMedPubDate><PubMedPubDate PubStatus="accepted"><Year>2020</Year><Month>11</Month><Day>12</Day></PubMedPubDate><PubMedPubDate PubStatus="entrez"><Year>2020</Year><Month>12</Month><Day>2</Day><Hour>5</Hour><Minute>30</Minute></PubMedPubDate><PubMedPubDate PubStatus="pubmed"><Year>2020</Year><Month>12</Month><Day>3</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate PubStatus="medline"><Year>2021</Year><Month>4</Month><Day>2</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate PubStatus="pmc-release"><Year>2020</Year><Month>12</Month><Day>1</Day></PubMedPubDate></History><PublicationStatus>epublish</PublicationStatus><ArticleIdList><ArticleId IdType="pubmed">33262488</ArticleId><ArticleId IdType="pmc">PMC7708472</ArticleId><ArticleId IdType="doi">10.1038/s41598-020-77768-7</ArticleId><ArticleId IdType="pii">10.1038/s41598-020-77768-7</ArticleId></ArticleIdList><ReferenceList><Reference><Citation>Yao X, et al. Epidemiological and etiological characteristics of herpangina and hand foot mouth diseases in Jiangsu, China, 2013&#x2013;2014. Hum. Vaccin Immunother. 2017;13:823&#x2013;830. doi: 10.1080/21645515.2016.1236879.</Citation><ArticleIdList><ArticleId IdType="doi">10.1080/21645515.2016.1236879</ArticleId><ArticleId IdType="pmc">PMC5404359</ArticleId><ArticleId IdType="pubmed">27768527</ArticleId></ArticleIdList></Reference><Reference><Citation>Guan HY, et al. Etiology of multiple non-EV71 and non-CVA16 enteroviruses associated with hand, foot and mouth disease in Jinan, China, 2009-June 2013. PLoS ONE. 2015;10:e0142733. doi: 10.1371/journal.pone.0142733.</Citation><ArticleIdList><ArticleId IdType="doi">10.1371/journal.pone.0142733</ArticleId><ArticleId IdType="pmc">PMC4642993</ArticleId><ArticleId IdType="pubmed">26562154</ArticleId></ArticleIdList></Reference><Reference><Citation>Wang CY, Lu FL, Wu MH, Lee CY, Huang LM. Fatal coxsackievirus A16 infection. Pediatr. Infect Dis. J. 2004;23:275&#x2013;276. doi: 10.1097/01.inf.0000115950.63906.78.</Citation><ArticleIdList><ArticleId IdType="doi">10.1097/01.inf.0000115950.63906.78</ArticleId><ArticleId IdType="pubmed">15014311</ArticleId></ArticleIdList></Reference><Reference><Citation>Xing W, et al. Hand, foot and mouth disease in China, 2008&#x2013;12: an epidemiological study. Lancet Infect. Dis. 2014;14:308&#x2013;318. doi: 10.1016/S1473-3099(13)70342-6.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/S1473-3099(13)70342-6</ArticleId><ArticleId IdType="pmc">PMC4035015</ArticleId><ArticleId IdType="pubmed">24485991</ArticleId></ArticleIdList></Reference><Reference><Citation>Tao J, et al. Epidemiology of 45,616 suspect cases of hand, foot and mouth disease in Chongqing, China, 2011&#x2013;2015. Sci. Rep. 2017;7:45630. doi: 10.1038/srep45630.</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/srep45630</ArticleId><ArticleId IdType="pmc">PMC5395817</ArticleId><ArticleId IdType="pubmed">28422128</ArticleId></ArticleIdList></Reference><Reference><Citation>Nikonov OS, Chernykh ES, Garber MB, Nikonova EY. Enteroviruses: classification, diseases they cause, and approaches to development of antiviral drugs. Biochemistry (Mosc). 2017;82:1615&#x2013;1631. doi: 10.1134/S0006297917130041.</Citation><ArticleIdList><ArticleId IdType="doi">10.1134/S0006297917130041</ArticleId><ArticleId IdType="pmc">PMC7087576</ArticleId><ArticleId IdType="pubmed">29523062</ArticleId></ArticleIdList></Reference><Reference><Citation>Deshpande JM, et al. Genomic characterization of two new enterovirus types, EV-A114 and EV-A121. J. Med. Microbiol. 2016;65:1465&#x2013;1471. doi: 10.1099/jmm.0.000380.</Citation><ArticleIdList><ArticleId IdType="doi">10.1099/jmm.0.000380</ArticleId><ArticleId IdType="pubmed">27902407</ArticleId></ArticleIdList></Reference><Reference><Citation>Ogi M, et al. Characterization of genome sequences and clinical features of coxsackievirus A6 strains collected in Hyogo, Japan in 1999&#x2013;2013. J. Med. Virol. 2017;89:1395&#x2013;1403. doi: 10.1002/jmv.24798.</Citation><ArticleIdList><ArticleId IdType="doi">10.1002/jmv.24798</ArticleId><ArticleId IdType="pubmed">28229467</ArticleId></ArticleIdList></Reference><Reference><Citation>Chen M, et al. Severe hand, foot and mouth disease associated with Coxsackievirus A10 infections in Xiamen, China in 2015. J. Clin. Virol. 2017;93:20&#x2013;24. doi: 10.1016/j.jcv.2017.05.011.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.jcv.2017.05.011</ArticleId><ArticleId IdType="pubmed">28577423</ArticleId></ArticleIdList></Reference><Reference><Citation>Weng Y, et al. Serotyping and genetic characterization of hand, foot, and mouth disease (HFMD)-associated enteroviruses of no-EV71 and non-CVA16 circulating in Fujian, China, 2011&#x2013;2015. Med. Sci. Monit. 2017;23:2508&#x2013;2518. doi: 10.12659/MSM.901364.</Citation><ArticleIdList><ArticleId IdType="doi">10.12659/MSM.901364</ArticleId><ArticleId IdType="pmc">PMC5452872</ArticleId><ArticleId IdType="pubmed">28539579</ArticleId></ArticleIdList></Reference><Reference><Citation>Yang Q, et al. Epidemiological and etiological characteristics of hand, foot, and mouth disease in Wuhan, China from 2012 to 2013: outbreaks of coxsackie viruses A10. J. Med. Virol. 2015;87:954&#x2013;960. doi: 10.1002/jmv.24151.</Citation><ArticleIdList><ArticleId IdType="doi">10.1002/jmv.24151</ArticleId><ArticleId IdType="pubmed">25754274</ArticleId></ArticleIdList></Reference><Reference><Citation>Wang J, et al. Epidemiological and serological surveillance of hand-foot-and-mouth disease in Shanghai, China, 2012&#x2013;2016. Emerg. Microbes Infect. 2018;7:1&#x2013;12.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC5837173</ArticleId><ArticleId IdType="pubmed">29362406</ArticleId></ArticleIdList></Reference><Reference><Citation>Second J, et al. Clinicopathologic analysis of atypical hand, foot, and mouth disease in adult patients. J. Am. Acad. Dermatol. 2016;76:722&#x2013;729. doi: 10.1016/j.jaad.2016.10.022.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.jaad.2016.10.022</ArticleId><ArticleId IdType="pubmed">28027826</ArticleId></ArticleIdList></Reference><Reference><Citation>Yang Q, et al. Two genotypes of Coxsackievirus A2 associated with hand, foot, and mouth disease circulating in China since 2008. PLoS ONE. 2016;11:e0169021. doi: 10.1371/journal.pone.0169021.</Citation><ArticleIdList><ArticleId IdType="doi">10.1371/journal.pone.0169021</ArticleId><ArticleId IdType="pmc">PMC5193457</ArticleId><ArticleId IdType="pubmed">28030650</ArticleId></ArticleIdList></Reference><Reference><Citation>Bian L, et al. Coxsackievirus A6: a new emerging pathogen causing hand, foot and mouth disease outbreaks worldwide. Expert Rev. Anti Infect. Ther. 2015;13:1061&#x2013;1071. doi: 10.1586/14787210.2015.1058156.</Citation><ArticleIdList><ArticleId IdType="doi">10.1586/14787210.2015.1058156</ArticleId><ArticleId IdType="pubmed">26112307</ArticleId></ArticleIdList></Reference><Reference><Citation>Zhang Y, et al. Molecular evidence of persistent epidemic and evolution of subgenotype B1 coxsackievirus A16-associated hand, foot, and mouth disease in China. J. Clin. Microbiol. 2010;48:619&#x2013;622. doi: 10.1128/JCM.02338-09.</Citation><ArticleIdList><ArticleId IdType="doi">10.1128/JCM.02338-09</ArticleId><ArticleId IdType="pmc">PMC2815627</ArticleId><ArticleId IdType="pubmed">20018819</ArticleId></ArticleIdList></Reference><Reference><Citation>Zong W, et al. Molecular phylogeny of Coxsackievirus A16 in Shenzhen, China, from 2005 to 2009. J. Clin. Microbiol. 2011;49:1659&#x2013;1661. doi: 10.1128/JCM.00010-11.</Citation><ArticleIdList><ArticleId IdType="doi">10.1128/JCM.00010-11</ArticleId><ArticleId IdType="pmc">PMC3122795</ArticleId><ArticleId IdType="pubmed">21325543</ArticleId></ArticleIdList></Reference><Reference><Citation>Hu Y, et al. Complete genome analysis of Coxsackievirus A2, A4, A5, and A10 strains isolated from hand, foot, and mouth disease patients in China revealing frequent recombination of human enterovirus A. J. Clin. Microbiol. 2011;49:2426&#x2013;2434. doi: 10.1128/JCM.00007-11.</Citation><ArticleIdList><ArticleId IdType="doi">10.1128/JCM.00007-11</ArticleId><ArticleId IdType="pmc">PMC3147834</ArticleId><ArticleId IdType="pubmed">21543560</ArticleId></ArticleIdList></Reference><Reference><Citation>Guan D, et al. Population dynamics and genetic diversity of C4 strains of human enterovirus 71 in Mainland China, 1998&#x2013;2010. PLoS ONE. 2012;7:e44386. doi: 10.1371/journal.pone.0044386.</Citation><ArticleIdList><ArticleId IdType="doi">10.1371/journal.pone.0044386</ArticleId><ArticleId IdType="pmc">PMC3440427</ArticleId><ArticleId IdType="pubmed">22984501</ArticleId></ArticleIdList></Reference><Reference><Citation>Esposito S, Principi N. Hand, foot and mouth disease: current knowledge on clinical manifestations, epidemiology, aetiology and prevention. Eur. J. Clin. Microbiol. Infect. Dis. 2018;37:391&#x2013;398. doi: 10.1007/s10096-018-3206-x.</Citation><ArticleIdList><ArticleId IdType="doi">10.1007/s10096-018-3206-x</ArticleId><ArticleId IdType="pubmed">29411190</ArticleId></ArticleIdList></Reference><Reference><Citation>Li W, et al. Large outbreak of herpangina in children caused by enterovirus in summer of 2015 in Hangzhou,Chian. Sci Rep. 2016;6:35388. doi: 10.1038/srep35388.</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/srep35388</ArticleId><ArticleId IdType="pmc">PMC5067559</ArticleId><ArticleId IdType="pubmed">27752104</ArticleId></ArticleIdList></Reference><Reference><Citation>Yip CC, et al. Recombinant coxsackievirus A2 and deaths of children, Hong Kong, 2012. Emerg. Infect. Dis. 2013;19:1285&#x2013;1288. doi: 10.3201/eid1908.121498.</Citation><ArticleIdList><ArticleId IdType="doi">10.3201/eid1908.121498</ArticleId><ArticleId IdType="pmc">PMC3739500</ArticleId><ArticleId IdType="pubmed">23876841</ArticleId></ArticleIdList></Reference><Reference><Citation>Chen L, et al. Molecular epidemiology of enteroviruses associated with severe hand, foot and mouth disease in Shenzhen, China, 2014&#x2013;2018. Arch. Virol. 2020 doi: 10.1007/s00705-020-04734-z.</Citation><ArticleIdList><ArticleId IdType="doi">10.1007/s00705-020-04734-z</ArticleId><ArticleId IdType="pmc">PMC7360124</ArticleId><ArticleId IdType="pubmed">32666145</ArticleId></ArticleIdList></Reference><Reference><Citation>Tsai HP, et al. An echovirus 18-associated outbreak of aseptic meningitis in Taiwan: epidemiology and diagnostic and genetic aspects. J. Med. Microbiol. 2011;60:1360&#x2013;1365. doi: 10.1099/jmm.0.027698-0.</Citation><ArticleIdList><ArticleId IdType="doi">10.1099/jmm.0.027698-0</ArticleId><ArticleId IdType="pubmed">21546563</ArticleId></ArticleIdList></Reference><Reference><Citation>Chen SP, et al. Comparison of clinical features between coxsackievirus A2 and enterovirus 71 during the enterovirus outbreak in Taiwan, 2008: a children&#x2019;s hospital experience. J. Microbiol. Immunol. Infect. 2010;43:99&#x2013;104. doi: 10.1016/S1684-1182(10)60016-3.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/S1684-1182(10)60016-3</ArticleId><ArticleId IdType="pubmed">20457425</ArticleId></ArticleIdList></Reference><Reference><Citation>Ward CD, Stokes MA, Flanegan JB. Direct measurement of the poliovirus RNA polymerase error frequency in vitro. J Virol. 1988;62:558&#x2013;562. doi: 10.1128/JVI.62.2.558-562.1988.</Citation><ArticleIdList><ArticleId IdType="doi">10.1128/JVI.62.2.558-562.1988</ArticleId><ArticleId IdType="pmc">PMC250568</ArticleId><ArticleId IdType="pubmed">2826815</ArticleId></ArticleIdList></Reference><Reference><Citation>Feng X, et al. A novel recombinant lineage's contribution to the outbreak of coxsackievirus A6-associated hand, foot and mouth disease in Shanghai, China, 2012&#x2013;2013. Sci. Rep. 2015;5:11700. doi: 10.1038/srep11700.</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/srep11700</ArticleId><ArticleId IdType="pmc">PMC4485158</ArticleId><ArticleId IdType="pubmed">26121916</ArticleId></ArticleIdList></Reference><Reference><Citation>Bell EJ, Cosgrove BP. Routine enterovirus diagnosis in a human rhabdomyosarcoma cell line. Bull. WHO. 1980;58:423&#x2013;428.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC2395914</ArticleId><ArticleId IdType="pubmed">6251982</ArticleId></ArticleIdList></Reference><Reference><Citation>Schmidt NJ, Ho HH, Lennette EH. Propagation and isolation of group A coxsackieviruses in RD cells. J. Clin. Microbiol. 1975;2:183&#x2013;185.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC274168</ArticleId><ArticleId IdType="pubmed">1176625</ArticleId></ArticleIdList></Reference><Reference><Citation>Schmidt NJ, Ho HH, Riggs JL, Lennette EH. Comparative sensitivity of various cell culture systems for isolation of viruses from wastewater and fecal samples. Appl. Environ. Microbiol. 1978;36:480&#x2013;486. doi: 10.1128/AEM.36.3.480-486.1978.</Citation><ArticleIdList><ArticleId IdType="doi">10.1128/AEM.36.3.480-486.1978</ArticleId><ArticleId IdType="pmc">PMC243072</ArticleId><ArticleId IdType="pubmed">215087</ArticleId></ArticleIdList></Reference><Reference><Citation>Menegus M, Hollick GE. Increased efficiency of group B coxsackievirus isolation from clinical specimens by use of BGM cells. J. Clin. Microbiol. 1982;15:945&#x2013;948. doi: 10.1128/JCM.15.5.945-948.1982.</Citation><ArticleIdList><ArticleId IdType="doi">10.1128/JCM.15.5.945-948.1982</ArticleId><ArticleId IdType="pmc">PMC272218</ArticleId><ArticleId IdType="pubmed">16789270</ArticleId></ArticleIdList></Reference><Reference><Citation>Pennino F, et al. Large-scale survey of human enteroviruses in wastewater treatment plants of a metropolitan area of southern Italy. Food Environ. Virol. 2018;10:187&#x2013;192. doi: 10.1007/s12560-017-9331-3.</Citation><ArticleIdList><ArticleId IdType="doi">10.1007/s12560-017-9331-3</ArticleId><ArticleId IdType="pubmed">29248990</ArticleId></ArticleIdList></Reference><Reference><Citation>Wecker I. The use of RD cells in the isolation of Echo type 30 virus from patients with aseptic meningitis. Med. Microbiol. Immunol. 1977;163:45&#x2013;51. doi: 10.1007/BF02126708.</Citation><ArticleIdList><ArticleId IdType="doi">10.1007/BF02126708</ArticleId><ArticleId IdType="pubmed">875886</ArticleId></ArticleIdList></Reference><Reference><Citation>Wecker I, Meulen V. RD cells in the laboratory diagnosis of enteroviruses. Med. Microbiol. Immunol. 1977;163:233&#x2013;240. doi: 10.1007/BF02125507.</Citation><ArticleIdList><ArticleId IdType="doi">10.1007/BF02125507</ArticleId><ArticleId IdType="pubmed">203835</ArticleId></ArticleIdList></Reference><Reference><Citation>Johnston SL, Siegel CS. Presumptive identification of enteroviruses with RD, HEp-2, and RMK Cell lines. J. Clin. Microbiol. 1990;28:1049&#x2013;1050. doi: 10.1128/JCM.28.5.1049-1050.1990.</Citation><ArticleIdList><ArticleId IdType="doi">10.1128/JCM.28.5.1049-1050.1990</ArticleId><ArticleId IdType="pmc">PMC267862</ArticleId><ArticleId IdType="pubmed">2161864</ArticleId></ArticleIdList></Reference><Reference><Citation>Herrmann EC, Person DA, Smith TF. Experience in laboratory diagnosis of enterovirus infections in routine medical practice. Mayo Clin. Proc. 1972;47:577&#x2013;586.</Citation><ArticleIdList><ArticleId IdType="pubmed">4340314</ArticleId></ArticleIdList></Reference><Reference><Citation>Mizuta K, Abiko C, Goto H, Murata T, Murayama S. Enterovirus isolation from children with acute respiratory infections and presumptive identification by a modified microplate method. Int. J. Infect. Dis. 2003;7:138&#x2013;142. doi: 10.1016/S1201-9712(03)90010-5.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/S1201-9712(03)90010-5</ArticleId><ArticleId IdType="pubmed">12839716</ArticleId></ArticleIdList></Reference><Reference><Citation>Zhang Y, et al. An emerging recombinant human enterovirus 71 responsible for the 2008 outbreak of hand foot and mouth disease in Fuyang city of China. Virol. J. 2010;7:94. doi: 10.1186/1743-422X-7-94.</Citation><ArticleIdList><ArticleId IdType="doi">10.1186/1743-422X-7-94</ArticleId><ArticleId IdType="pmc">PMC2885340</ArticleId><ArticleId IdType="pubmed">20459851</ArticleId></ArticleIdList></Reference><Reference><Citation>Mao Q, et al. Coxsackievirus A16: epidemiology, diagnosis, and vaccine. Hum. Vaccin Immunother. 2014;10:360&#x2013;367. doi: 10.4161/hv.27087.</Citation><ArticleIdList><ArticleId IdType="doi">10.4161/hv.27087</ArticleId><ArticleId IdType="pmc">PMC4185891</ArticleId><ArticleId IdType="pubmed">24231751</ArticleId></ArticleIdList></Reference><Reference><Citation>Fang CY, Liu CC. Recent development of enterovirus A vaccine candidates for the prevention of hand, foot, and mouth disease. Expert Rev. Vaccines. 2018;17:819&#x2013;831. doi: 10.1080/14760584.2018.1510326.</Citation><ArticleIdList><ArticleId IdType="doi">10.1080/14760584.2018.1510326</ArticleId><ArticleId IdType="pubmed">30095317</ArticleId></ArticleIdList></Reference><Reference><Citation>Lee M, et al. Molecular diagnosis and clinical presentations of enteroviral infections in Taipei during the 2008 epidemic. J. Microbiol. Immunol. Infect. 2011;44:178&#x2013;183. doi: 10.1016/j.jmii.2011.01.018.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.jmii.2011.01.018</ArticleId><ArticleId IdType="pubmed">21524611</ArticleId></ArticleIdList></Reference><Reference><Citation>Li Y, et al. Effectiveness of EV-A71 vaccination in prevention of paediatric hand, foot, and mouth disease associated with EV-A71 virus infection requiring hospitalisation in Henan, China, 2017&#x2013;18: a test-negative case-control study. Lancet Child Adolesc. Health. 2019;3:697&#x2013;704. doi: 10.1016/S2352-4642(19)30185-3.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/S2352-4642(19)30185-3</ArticleId><ArticleId IdType="pmc">PMC8713082</ArticleId><ArticleId IdType="pubmed">31375313</ArticleId></ArticleIdList></Reference><Reference><Citation>Ge S, et al. Specific primer amplification of the VP1 region directed by 5&#x2019;UTR sequence analysis: enterovirus testing and identification in clinical samples from hand-foot-and-mouth disease patients. J. Virol. Methods. 2013;193:463&#x2013;469. doi: 10.1016/j.jviromet.2013.06.009.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.jviromet.2013.06.009</ArticleId><ArticleId IdType="pubmed">23769858</ArticleId></ArticleIdList></Reference><Reference><Citation>Oberste MS, Nix WA, Maher K, Pallansch MA. Improved molecular identification of enteroviruses by RT-PCR and amplicon sequencing. J. Clin. Virol. 2003;26:375&#x2013;377. doi: 10.1016/S1386-6532(03)00004-0.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/S1386-6532(03)00004-0</ArticleId><ArticleId IdType="pubmed">12637088</ArticleId></ArticleIdList></Reference></ReferenceList></PubmedData></PubmedArticle></PubmedArticleSet>